Skip to main content

Table 2 Average annual direct medical costs and cost components by disease states (RMB)

From: The trend of direct medical costs and associated factors in patients with chronic hepatitis B in Guangzhou, China: an eight-year retrospective cohort study

Disease stages

Total costs

Lab tests and imaging examinations costs (%)

Antiviral therapy costs (%)

Other medicine costs (%)

Bed and nursing costs (%)

Other costs (%)

Hepatoprotective drugs costs (%)

Chinese medicine costs (%)

Anti-fibrotic medicine costs (%)

Outpatients

         

 CHB

3731.05

612.59 (16.42)

2115.80 (56.71)

973.74 (26.10)

26.77 (0.72)

402.26 (10.78)

321.68 (8.62)

192.66 (5.16)

 Cirrhosis

5871.55

791.89 (13.49)

2762.03 (47.04)

2280.05 (38.83)

35.57 (0.61)

352.18 (6.00)

1171.40 (19.95)

1317.66 (22.44)

 HCC

3734.82

736.14 (19.71)

1347.16 (36.07)

1597.73 (42.78)

51.37 (1.38)

230.27 (6.17)

897.42 (24.03)

782.29 (20.95)

 All

4019.52

638.01 (15.87)

2195.07 (54.61)

1156.11 (28.76)

28.20 (0.70)

393.77 (9.80)

442.03 (11.00)

350.25 (8.71)

Inpatients

         

 CHB

12,967.77

3582.27 (27.62)

1248.97 (9.63)

5549.54 (42.79)

1185.32 (9.14)

1401.66 (10.81)

2827.57 (21.80)

274.13 (2.11)

80.71 (0.62)

 Cirrhosis

23,869.57

5352.03 (22.42)

1223.75 (5.13)

11,798.04 (49.43)

1479.03 (6.20)

4016.72 (16.83)

3352.95 (14.05)

781.21 (3.27)

534.99 (2.24)

 HCC

27,996.54

5513.45 (19.69)

765.67 (2.73)

12,775.57 (45.63)

1294.78 (4.62)

7647.07 (27.31)

2594.88 (9.27)

993.19 (3.55)

441.90 (1.58)

 All

18,801.96

4443.79 (23.63)

1159.99 (6.17)

8659.90 (46.06)

1292.78 (6.87)

3245.50 (17.26)

2947.68 (15.68)

548.87 (2.92)

279.21 (1.49)